Prevention of Future Deaths reports · 2025

David Tighe

Regulation 28 report to prevent future deaths, reference 2025-0158, written 9 Jan 2025. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report9 Jan 2025
Reference2025-0158
DeceasedDavid Tighe
CoronerMichael Walsh
Coroner areaOxfordshire
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Organisation namedOxford University Hospitals NHS Foundation Trust
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

THE OXFORDSHIRE CORONER’S COURT

IN THE MATTER OF AN INQUEST TOUCHING THE DEATH OF

DAVID VINCENT TIGHE

1

2

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS

THIS REPORT IS BEING SENT TO:

1. Oxford University Hospitals NHS Foundation Trust

CORONER

I am Michael Walsh, HM Assistant Coroner, for the coroner area of Oxfordshire

CORONER’S LEGAL POWERS

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009
and Regulations 28 and 29 of the Coroners (Investigations) Regulations 2013.

https://www.legislation.gov.uk/ukpga/2009/25/schedule/5/paragraph/7

https://www.legislation.gov.uk/uksi/2013/1629/part/7/made

3

INVESTIGATION and INQUEST

The inquest into the death of Mr David Vincent Tighe, aged 59, was opened on 26th April
2023. The investigation concluded at the end of the inquest on 20th December 2024.

The medical cause of death was:
Ia
Ib
Ic

Sepsis due to Bronchopneumonia
Enterocolitis with Paralytic Ileus
Metastatic Adenocarcinoma of Oesophagus Treated with Chemotherapy

II

Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease

The Narrative conclusion to the inquest was:
David died due to complications of treatment for chemotherapy-induced enterocolitis;
contributed to by Neglect.

4

CIRCUMSTANCES OF THE DEATH

David was a 59-year-old man who had been diagnosed with adenocarcinoma of the
gastro-oesophageal junction in November 2022. With chemotherapy treatment his
prognosis was at least a year, and he was being treated with the intention of prolonging
his life.
He subsequently suffered chemotherapy-induced enterocolitis, which was a known
complication of his treatment, and related symptoms required his admission to Churchill
hospital on 02.02.2023.
During treatment in hospital, David suffered three instances of aspiration of bile into his
lungs when he was laid flat, that should have been avoided.
The Ryles tube being used to drain bile from his stomach, and the amount of bile being
drained, were insufficiently monitored, and the Ryles tube became displaced following
an episode of vomiting, on 08.02.2023, causing ineffective and/or partial drainage over

1

 several hours. He was also noted to have bile in his mouth on the morning of
09.02.2023.  There was no discrete policy in place for the management of Ryles tubes,
and no repeat position check forms were used, although they were said to exist.
Had displacement been recognised in a timely manner and/or had the presence of bile
in David’s mouth been escalated in a timely manner, all events of aspiration should have
been avoided, by virtue of the Ryles tube being repositioned or replaced to provide
effective drainage; and/or by virtue of advice being given not to lay David flat, or to do so
with particular caution. Instead, no particular caution was taken when laying David flat
and he suffered aspiration which contributed in a more than minimal way to
bronchopneumonia and sepsis from which David died on 11.02.2023.
CORONER’S CONCERNS

5

During the course of the inquest the evidence revealed matters giving rise to concern. In
my opinion there is a risk that future deaths could occur unless action is taken. In the
circumstances it is my statutory duty to report to you.

The MATTERS OF CONCERN are as follows.   –

Concerns directed to Oxford University Hospitals NHS Foundation Trust

CONCERNS

Absence of a Ryles tube policy:

1. At the time of David’s death there was no separate policy for Ryles tubes, and
clinicians were required to apply the modest Royal Marsden Manual guidance,
and/or note that the practice consideration and care requirements for Ryles tubes
were not dissimilar to that for nasogastric tubes used for enteral administration, as
per the Trust’s “Insertion, Use and Care of Nasogastric Feeding Tubes in Adults:
Policy and Procedure”, October 2018 (‘NG feeding tube policy’), which provided
limited advice.
Evidence was given that a Ryles tube policy was required and that there was
motivation at the Trust to provide one, albeit none has been forthcoming in the 20
months since David’s death.
Evidence was also given that an NG tube “Position Record” for recording “Repeat
Position Checks” was in use for Ryles tubes (similar to the “Nasogastric Feeding
Tubes Position Record - Repeat Position Checks” document at Appendix 11 / page
53 of 55 of the Trust’s NG feeding tube policy), but several staff were unaware of
such a document existing for Ryles tubes, and no such Ryles Tubes records were
ever disclosed.
Expert evidence was given that it was suboptimal care not to have a specific policy
for the management of Ryles tubes given the risks associated with such an invasive
procedure that required ongoing monitoring.
At the time of the inquest, the Trust’s expressed intention was to provide a Ryles
tube policy, and assistance was said to have been requested from the Shelford
Group (an external body), although conversations about such a policy were said to
have started within the Trust itself, as early as April or May of 2023.
It is therefore unclear whether a Ryles tube policy would ever be produced
notwithstanding one appears to be accepted as being required.
The absence of policy where a need has been identified creates an obvious risk of
death to future patients, due to the absence of guidance and procedure to assist
clinicians undertaking such an invasive procedure.

Use of a narrowly focussed structured review by a treating clinician:

2. On 18.03.2023 the Trust undertook a Structured Review to consider learning from
David’s death.  Evidence was given that the Structured Review was intended to be
narrow in focus, as opposed to a more comprehensive serious incident report.  As a
result, it did not involve taking information from staff, but was a 2-hour review of the

2

 medical records across five different areas, undertaken in a highly pressured
environment.
The Structured Review consequently overlooked considering several issues
including:
(i)
(ii)

missing bile drainage entries.
missing clinical observations contrary to Trust policy (“Recognising the
Acutely Ill and Deteriorating Adult Patient (RAID) Policy, April 2021).
the absence of Repeat Position Checks for the Ryles tube.
the absence of any written record of family concerns that were raised with a
ward sister.

(iii)
(iv)

Evidence was given by an author of the Structured Review that he considered its
scope was in fact too limited, and in future, he would advise suspending such a
narrow review.
That author was also a clinician involved with David’s care in spite of the potential
for conflict being correctly raised with the Trust in advance.
Any inability to adequately investigate such incidents, without undue restriction in
scope, without time pressure, and without any appearance of conflict or bias,
creates a risk of death to future patients, as oversights or omissions in care, policy
or procedure that may be missed by a narrow review, may remain unidentified and
unremedied.

6

ACTION SHOULD BE TAKEN

In my opinion action should be taken to prevent future deaths and I believe your
organisation has the power to take such action in relation to the concerns above.

7

YOUR RESPONSE

You are under a duty to respond to this report within 56 days of the date of this report,
namely by 6h March 2025. I, the coroner, may extend the period.

Your response must contain details of action taken or proposed to be taken, setting out
the timetable for action. Otherwise, you must explain why no action is proposed.

8

COPIES and PUBLICATION

I have sent a copy of my report to the Chief Coroner and to the following Interested
Persons:

1.
2.

David’s family
Oxford University Hospitals NHS Foundation Trust

I am also under a duty to send the Chief Coroner a copy of your response.

The Chief Coroner may publish either or both in a complete or redacted or summary
form. He may send a copy of this report to any person who he believes may find it useful
or of interest. You may make representations to me, the coroner, at the time of your
response, about the release or the publication of your response by the Chief Coroner.

9

9th January 2025

Michael Walsh
HM Assistant Coroner
Oxfordshire Coroner’s Court

3

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Oxfordshire University Hospitals NHS Foundation Trust (PDF)
05 March 2025 

Chief Executive Officer 
Oxford University Hospitals 
NHS Foundation Trust 
Trust Headquarters, Level 3 
John Radcliffe Hospital 
Headley Way 
Oxford OX3 9DU 

Your ref: 

Mr Michael Walsh  

HM Assistant Coroner for Oxfordshire 

Sent via email only to: 

Dear Mr Walsh 

Regulation 28 Report/Prevention of Future Deaths 

Inquest into the Death of Mr David Vincent Tighe 

Following the death of Mr David Vincent Tighe, and subsequent inquest hearing from 
Wednesday 11 December - Friday 13 December 2024 and Monday 16 December – 
Wednesday 18 December 2024, I write as CEO of Oxford University Hospitals NHS 
Foundation Trust (OUH), to provide a response to your Regulation 28 Report dated 9 
January 2025.  
I would like to start by expressing to Mr Tighe’s family how sorry I am for their loss.  

Mr  Tighe  had  been  diagnosed  with  adenocarcinoma  of  the  gastro-oesophageal 
junction  in  November  2022.  He  commenced  chemotherapy  treatment  with  a  life 
expectancy  of  at  least  a  year,  and  subsequently  suffered  chemotherapy-induced 
enterocolitis, which was a known complication of his treatment and related symptoms 
requiring admission to the Oncology Ward, Churchill Hospital on 2 February 2023.  

You recorded a narrative conclusion on 18 December 2024 as follows: “David (Tighe) 
died  due  to  complications  of  treatment  for  chemotherapy-induced  enterocolitis; 
contributed to by Neglect.”    

The medical cause of death was confirmed after hearing evidence from OUH clinicians 
and external nursing expert by you to be: 

1a Sepsis due to Bronchopneumonia 
1b Enterocolitis with Paralytic Ileus 
1c Metastatic Adenocarcinoma of Oesophagus treated with Chemotherapy 
2)  Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease 

Page 1 of 3 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 In your conclusion you set out two areas of concern, and for each I can provide the 
following additional information: 

1.  Absence of a Ryles Tube Policy 

There is no nationally recognised policy for wide bore nasogastric (Ryles) tubes for 
aspiration drainage.  The existing OUH policy is for nasogastric (NG) tubes when 
used for feeding.  Current practice for insertion of a wide bore tube is based on the 
Royal Marsden manual of clinical and cancer nursing procedures.  Only one of the 
9 similar Trusts who we approached has a policy which is virtually identical to the 
Royal Marsden manual. 

The  Oncology  Matron  has  set  up  a  working  group  to  review  current  practice, 
evaluate external resources and produce a Trust wide policy.  The policy will set 
out  the  Trust  standards  for  managing  patients  with  Ryles  Tubes  for  aspiration 
drainage.    The  working  group  includes  nursing  and  medical  staff  across  the 
organisation  including  anaesthetics,  surgery,  oncology  and  gastroenterology 
representatives.  The first meeting was held on 3 February 2025.  The policy will 
be  presented  to  the  OUH  Clinical  Policy  Group  by April  2025  and  a  Trust  wide 
safety message will be communicated to all staff which will include the link to this 
policy.  The publication of the policy will be followed by training of the appropriate 
staff through ward-based learning delivered by clinical educators.   

2.  Use of a narrowly focussed Structured Review by a treating clinician  

The  Trust  has  a  robust  process  for  training  clinicians  in  performing  Structured 
Judgement Reviews (SJRs).  The training highlights the need to review the whole 
case record including the nursing records.  It directs the reviewer to contact any 
individual or team if there are concerns about the quality of care provided.  There 
is no limit put on the length of time to undertake an SJR. Over 230 clinicians within 
OUH have been trained to date.   

Since this case we have strengthened our mortality review processes in two ways.  
Firstly,  we  have  formalised  the  process  for  feeding  back  family  concerns  to  the 
clinical  team  and  incorporating  these  into  the  mortality  review.    The  Medical 
Examiner Officers speak to every bereaved family of a patient who dies in OUH 
and feed back, in a structured format, any concerns from the family about the care 
of the deceased.  This feedback is directed to the Divisional governance team and 
responsible clinical team who must then address this within the mortality review. 

Secondly, we have modified the SJR template to ask the author if they have any 
concerns about the scope or focus of the review, giving them an explicit opportunity 
to  raise  any  concerns  which  can  then  be  addressed  proactively  by  the  Trust 
through providing additional support.  Prior to completing the review, the reviewer 
will  also  be  asked  to  confirm  whether  they  have  any  conflict  of  interest  such  as 
having  been  involved  in  the  care  of  the  patient.    This  will  provide  stronger 
assurance  that  all  reviews  investigate  deaths  without  restriction  in  scope,  time 
pressure or appearance of conflict or bias.   

Page 2 of 3 

 
 
 In  addition  to  the actions  above,  the  learning  from  this case  will  be  presented  on  5 
March  at  Oncology  Clinical  Governance  meeting  and  will  also  be  presented  at  the 
OUH Clinical Governance Committee and the OUH Mortality Review Group over the 
next 2 months.   

I  hope  that  this  response  will  reassure  you  that  we  have  taken  your  concerns  very 
seriously and implemented appropriate actions following this inquest.  

Yours sincerely 

Chief Executive Officer 
Oxford University Hospitals NHS Foundation Trust 

Page 3 of 3

Related reports

Other reports by Michael Walsh

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Oxford University Hospitals NHS Foundation Trust

See every Prevention of Future Deaths report matching Oxford University Hospitals NHS Foundation Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.